HomeFile

File

View Category
Structural Heart Disease

ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation

Severe tricuspid regurgitation (TR) is associated with chronic systemic venous congestion, recurrent hospitalizations for heart failure (HF),...
Dr. Juan Manuel Pérez -
Learn More
Femoropopliteal

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and...
Dr. Juan Manuel Pérez -
Learn More
Coronary disease

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex coronary lesions remains a relevant clinical challenge. The IVUS-CHIP...
Dr. Juan Manuel Pérez -
Learn More
Chronic Ischemic cardiopathy

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its...
Dr. Juan Manuel Pérez -
Learn More
Structural Heart Disease

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent...
Dr. Juan Manuel Pérez -
Learn More
Chronic Ischemic cardiopathy

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering...
Dr. Juan Manuel Pérez -
Learn More
Left Atrial Apendix Closure

ACC 2026 | CHAMPION-AF: Left atrial appendage closure versus anticoagulation in atrial fibrillation

Can left atrial appendage closure challenge anticoagulation as the standard of care in atrial fibrillation? Atrial fibrillation (AF)...
Dr. Juan Manuel Pérez -
Learn More
Chronic Coronary Syndromes

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to...
Dr. Omar Tupayachi -
Learn More